Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 3, 2013, Pages 211-215

  Craig, Timothy J ^a   Rojavin, Mikhail A ^b   Machnig, Thomas ^c   Keinecke, Heinz Otto ^d   Bernstein, Jonathan A ^e  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b CSL Behring LLC   (United States)

^c CSL BEHRING GMBH   (Germany)

^d ACCOVION GMBH   (Germany)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; PLACEBO;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; EARLY INTERVENTION; FEMALE; GENERAL PATHOLOGICAL PARAMETERS; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POST HOC ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; THERAPY DELAY; TIME TO COMPLETE RESOLUTION; TIME TO ONSET OF SYMPTOM RELIEF; TIME TO TREATMENT;

ADOLESCENT; ADULT; AGED; ANGIOEDEMAS, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883464871     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.06.021     Document Type: Article

References (20)

1. M. Cugno, A. Zanichelli, F. Foieni, S. Caccia, and M. Cicardi C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress Trends Mol Med 15 2009 69 78
2. B.L. Zuraw Clinical practice: hereditary angioedema N Engl J Med 359 2008 1027 1036
3. T.J. Craig, R.J. Levy, and R.L. Wasserman Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks J Allergy Clin Immunol 124 2009 801 808
4. M. Kunschak, W. Engl, and F. Maritsch A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema Transfusion 38 1998 540 549
5. B.L. Zuraw, P.J. Busse, and M. White Nanofiltered C1 Inhibitor concentrate for treatment of hereditary angioedema N Engl J Med 363 2010 513 522
6. T. Bowen, M. Cicardi, and H. Farkas 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema Allergy Asthma Clin Immunol 6 2010 24
7. H.J. Longhurst, H. Farkas, and T. Craig HAE international home therapy consensus document Allergy Asthma Clin Immunol 6 2010 22
8. M. Cicardi, K. Bork, and T. Caballero Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group Allergy 67 2012 147 157
9. K. Bork, G. Meng, P. Staubach, and J. Hardt Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema Transfusion 45 2005 1774 1784
10. W. Kreuz, E. Rusicke, I. Martinez-Saguer, E. Aygören- Pürsün, C. Heller, and T. Klingebiel Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema Transfusion 52 2012 100 107
11. L.M. Tourangeau, A.J. Castaldo, D.K. Davis, J. Koziol, S.C. Christiansen, and B.L. Zuraw Safety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy Int Arch Allergy Immunol 157 2012 417 424
12. M. Levi, G. Choi, C. Picavet, and C.E. Hack Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency J Allergy Clin Immunol 117 2006 904 908
13. T.J. Craig, A.K. Bewtra, and S.L. Bahna C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks: final results of the IMPACT 2 study Allergy 66 2011 1604 1611
14. T.J. Craig, A.K. Bewtra, and D. Hurewitz Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks Allergy Asthma Proc 33 2012 354 361
15. D.R. Cox Regression models and life-tables J R Statist Soc 34 1972 187 220
16. J.A. Bernstein Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies Ann Allergy Asthma Immunol 100 suppl 2008 S41 S46
17. K. Bork, J. Hardt, K.H. Schicketanz, and N. Ressel Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency Arch Intern Med 163 2003 1229 1235
18. W. Kreuz, I. Martinez-Saguer, E. Aygören-Pürsün, E. Rusicke, C. Heller, and T. Klingebiel C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis Transfusion 49 2009 1987 1995
19. J. Björkqvist, A. Sala-Cunill, and T. Renné Hereditary angioedema: a bradykinin-mediated swelling disorder Thromb Haemost 109 2013 368 374
20. E. Banta, P. Horn, and T.J. Craig Response to ecallantide treatment of acute attacks of hereditary angioedema based on time to intervention: results from the EDEMA clinical trials Allergy Asthma Proc 32 2011 319 324